1-4 of 4
P. Moreau
Close
Sort by
Journal Articles

A Multicenter Prospective Randomized Study Testing Non-Inferiority of Thalidomide 100 mg/day as Compared with 400 mg/day in Patients with Refractory/Relapsed Multiple Myeloma: First Results of the Final Analysis of the IFM 01-02 Study.

Ibrahim Yakoub-Agha, C. Hulin, C. Doyen, L. Benboubker, L. Voillat, K. Bouabdallah, G. Guillerm, P. Moreau, F. Maloisel, A.M. Stoppa, B. Pegourie, P. Rodon, M. Dib, P. Casassus, B. Slama, E. Voog, H. Jardel, P. Collet, M. Wettervald, A.M. Peny, P. Mineur, C. Duguet, R. Zerbib, T. Facon, J.Y. Mary
Journal: Blood
Blood (2005) 106 (11): 364.
https://doi.org/10.1182/blood.V106.11.364.364
Published: 2005
Journal Articles

Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients with AL (Primary) Amyloidosis: Results of the French Multicentric Randomized Trial (MAG and IFM Intergroup).

A. Jaccard, P. Moreau, V. Leblond, X. Leleu, L. Benboubker, O. Hermine, C. Recher, M. Malphette, B. Lioure, B. Royer, B. Grosbois, J. Jaubert, P.M. Preux, M. Cogne, J.P. Fermand
Journal: Blood
Blood (2005) 106 (11): 421.
https://doi.org/10.1182/blood.V106.11.421.421
Published: 2005
Journal Articles

Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study

E Solary, B Witz, D Caillot, P Moreau, B Desablens, JY Cahn, A Sadoun, B Pignon, C Berthou, F Maloisel, D Guyotat, P Casassus, N Ifrah, Y Lamy, B Audhuy, P Colombat, JL Harousseau
Journal: Blood
Blood (1996) 88 (4): 1198–1205.
https://doi.org/10.1182/blood.V88.4.1198.bloodjournal8841198
Published: 1996
Journal Articles

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement [letter]

P Moreau, N Milpied, P de Faucal, T Petit, P Herbouiller, R Bataille, JL Harousseau
Journal: Blood
Blood (1996) 87 (7): 3063–3064.
https://doi.org/10.1182/blood.V87.7.3063.bloodjournal8773063
Published: 1996